Immune abnormalities in patients with autism
The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
We have begun an investigation on the immune systems of patients with autism in attempt to determine if immune mechanisms are involved in the development of this severe developmental disorder. A study of 31 autistic patients has revealed several immune-system abnormalities, including reduced responsiveness in the lymphocyte blastogenesis assay to phytohemagglutinin, concanavalin A, and pokeweed mitogen; decreased numbers of T lymphocytes; and an altered ratio of helper to suppressor T cells. Immune-system abnormalities may be directly related to underlying biologic processes of autism, or these changes may be an indirect reflection of the actual pathologic mechanism.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“T-cell skewing to a TH2 phenotype (which is considered ‘anti-inflammatory’ and found in a subset of the ASD population) has been associated with better cognitive and adaptive behaviour126,131, but in another study, elevated levels of the classic TH2 cytokine IL-4 have been associated with greater impairments in non-verbal communication119.”
From Immune mediators in the brain and peripheral tissues in autism spectrum disorder (2015) · cites this paper as [126]
In the citing paper
“circulating levels of CD4+ T cell populations are low, biased towards an anti-inflammatory (TH2) profile and exhibit a dysfunctional response to stimulation in individuals with ASD126–130.”
From Immune mediators in the brain and peripheral tissues in autism spectrum disorder (2015) · cites this paper as [126]
In the citing paper
“A 1986 study found a reduced number of T cells in individuals with autism, as well as an altered helper to suppressor T-cell ratio (Warren et al, 1986)”
From The Role of the Immune System in Autism Spectrum Disorder (2017) · cites this paper as Warren et al, 1986
Citations
Cites
Clinical and Experimental Immunology
Kay, H. (1966) · PubMed Central · Cited by 2,177
Book Review: Clinical and Experimental Immunology
Kay, H. (1966) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591576605900860 · Cited by 2,176
(1983) · Neuropsychobiology · doi:10.1159/000117925 · Cited by 840
Increased Blood Serotonin and Platelets in Early Infantile Autism
Ritvo, E. R. (1970) · Archives of General Psychiatry · doi:10.1001/archpsyc.1970.01750060086009 · Cited by 248
Thomas, Y., Rogozinski, L., Irigoyen, O. H., Friedman, S. M., Kung, P. C., Goldstein, G., & Chess, L. (1981) · The Journal of experimental medicine · doi:10.1084/jem.154.2.459 · Cited by 243 · cited 1×
“However, some cells expressing the OKT4 marker have been reported to have a suppressor cell function instead of a helper function ( Thomas et al., 1981 ).”
BackgroundImmunologic and Coagulation Disorders in Chlorpromazine-Treated Patients
ZARRABI, M. H., ZUCKER, S., MILLER, F., DERMAN, R. M., ROMANO, G. S., HARTNETT, J. A., & VARMA, A. O. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-91-2-194 · Cited by 231
Schleifer, S. J. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790250023003 · Cited by 222
Depressed lymphocyte responsiveness in autistic children
Stubbs, E. G., Crawford, M. L., Burger, D. R., & Vandenbark, A. A. (1977) · Journal of Autism and Childhood Schizophrenia · doi:10.1007/bf01531114 · Cited by 202 · cited 2×
“The current study confirms an earlier finding ( Stubbs et al., 1977 ) that lymphocytes of patients with autism have defective response to the T-cell mitogen PHA, and indicates that lymphocytes of autistic patients also have significantly reduced responses to the T-cell mitogen con A and the B-cell Immune Abnormalities…”
BackgroundResultAbnormal immune response to brain tissue antigen in the syndrome of autism
(1982) · American Journal of Psychiatry · doi:10.1176/ajp.139.11.1462 · Cited by 136
Stubbs, E. G. (1976) · Journal of Autism and Developmental Disorders · doi:10.1007/bf01543467 · Cited by 96
Cited by
Chauhan, A., & Chauhan, V. (2006) · Pathophysiology · doi:10.1016/j.pathophys.2006.05.007 · Cited by 656
Perinatal risk factors for infantile autism
Hultman, C. M., Sparén, P., & Cnattingius, S. (2002) · Epidemiology · doi:10.1097/00001648-200207000-00009 · Cited by 561
The Role of the Immune System in Autism Spectrum Disorder
Meltzer, A., & Van de Water, J. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2016.158 · Cited by 533
The immune response in autism: a new frontier for autism research
Ashwood, P., Wills, S., & Van de Water, J. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1205707 · Cited by 528
“Immune aberrations consistent with a dysregulated immune response reported in autistic children include decreased peripheral lymphocyte numbers [30], decreased response to T 2 Journal of Leukocyte Biology Volume 80, July 2006 http://www.jleukbio.org cell mitogens [26, 27], incomplete or partial T cell activation evinc…”
BackgroundInfluentialImmune mediators in the brain and peripheral tissues in autism spectrum disorder
Estes, M. L., & McAllister, A. K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3978 · Cited by 514
Immunity, neuroglia and neuroinflammation in autism
Pardo, C. A., Vargas, D. L., & Zimmerman, A. W. (2005) · International Review of Psychiatry · doi:10.1080/02646830500381930 · Cited by 460
“Abnormalities of both humoral and cellular immune functions have been described in small studies of children with autism (N1⁄4 10–36), and include decreased production of immunoglobulins or B and T-cell dysfunction (Warren et al., 1986).”
BackgroundBelmonte, M. K., Cook, E. H., Anderson, G. M., Rubenstein, J. L. R., Greenough, W. T., Beckel-Mitchener, A., Courchesne, E., Boulanger, L. M., Powell, S. B., Levitt, P. R., et al. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001499 · Cited by 442
“abnormal T cell populations and functions [217, 251, 255, 265, 83], reduced NK cell activity [250], and lower Th1 and higher Th2-like cytokines [100].”
BackgroundElevated cytokine levels in children with autism spectrum disorder
Molloy, C. A., Morrow, A. L., Meinzen-Derr, J., Schleifer, K., Dienger, K., Manning-Courtney, P., Altaye, M., & Wills-Karp, M. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.11.007 · Cited by 386
“, who further reported that children with ASD had a reduced number of T lymphocytes, especially CD4 cells (Warren et al., 1986).”
BackgroundResultCroen, L. A., Grether, J. K., Yoshida, C. K., Odouli, R., & Van de Water, J. (2005) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.159.2.151 · Cited by 359
Can Children with Autism Recover? If So, How?
Helt, M., Kelley, E., Kinsbourne, M., Pandey, J., Boorstein, H., Herbert, M., & Fein, D. (2008) · Neuropsychology Review · doi:10.1007/s11065-008-9075-9 · Cited by 353
“Many children with ASD may experience some form of immune compromise (Warren et al. 2005).”
BackgroundSchneider, T., Roman, A., Basta-Kaim, A., Kubera, M., Budziszewska, B., Schneider, K., & Przewłocki, R. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.02.011 · Cited by 337
Autism: a novel form of mercury poisoning
Bernard, S., Enayati, A., Redwood, L., Roger, H., & Binstock, T. (2001) · Medical Hypotheses · doi:10.1054/mehy.2000.1281 · Cited by 348
Activation of the Inflammatory Response System in Autism
Croonenberghs, J., Bosmans, E., Deboutte, D., Kenis, G., & Maes, M. (2002) · Neuropsychobiology · doi:10.1159/000048665 · Cited by 322
Immunological Findings in Autism
Cohly, H. H. P., & Panja, A. (2005) · International Review of Neurobiology · doi:10.1016/s0074-7742(05)71013-8 · Cited by 262
“This includes changes in the numbers and functions of macrophages, T cells, B cells, and natural killer cell activity (Gupta 2000; Warren et al., 1986, 1987).”
BackgroundEnstrom, A. M., Lit, L., Onore, C. E., Gregg, J. P., Hansen, R. L., Pessah, I. N., Hertz-Picciotto, I., Van de Water, J. A., Sharp, F. R., & Ashwood, P. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2008.08.001 · Cited by 257
“Despite reported increases in inflammatory mediators in plasma and CNS tissue, immune cells isolated from individuals with ASD fail to respond appropriately to mitogen stimulation, such as phytohemagglutinin (Stubbs and Crawford, 1977; Warren et al., 1986).”
BackgroundTh1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism
Gupta, S., Aggarwal, S., Rashanravan, B., & Lee, T. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00021-6 · Cited by 250
“Warren et al., 1986; Gupta et al., 1996a increased levels Ž .of serum IgM and IgE Gupta et al., 1996a ; presence of Žautoantibodies to neural tissues Todd et al., 1988; Singh .et al., 1993 ; and positive response to transfer factor Ž .”
Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders
Connolly, A. M., Chez, M. G., Pestronk, A., Arnold, S. T., Mehta, S., & Deuel, R. K. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70248-9 · Cited by 236
Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism
Martin, L. A., Ashwood, P., Braunschweig, D., Cabanlit, M., Van de Water, J., & Amaral, D. G. (2008) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2007.12.007 · Cited by 231
“These include suppressed cell-mediated and humoral responses to pathogens (Stubbs and Crawford, 1977; Warren et al., 1987; Warren et al., 1986), and active inflammation and autoantibody reactions to brain tissue or proteins (Ashwood and Van de Water, 2004; Vargas et al., 2005; Weizman et al., 1982).”
Bauman, M. (2006) · Johns Hopkins University Press eBooks · doi:10.1353/book.3225 · Cited by 214
de Theije, C. G. M., Wu, J., da Silva, S. L., Kamphuis, P. J., Garssen, J., Korte, S. M., & Kraneveld, A. D. (2011) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2011.07.013 · Cited by 202
“, 2010) or immune (Burgess et al., 2006; Warren et al., 1986) changes.”
Smalley, S. L. (1997) · The American Journal of Human Genetics · doi:10.1086/515485 · Cited by 200
“Immunological abnormalities (Warren et al. 1986, 1990), as well as early prenatal insults in developmentet al. (1996) excluded a significant proportion of the X chromosome as a candidate for containing a gene of (for review, see Nelson 1991), are evident in some cases of AD.”
BackgroundVojdani, A., Campbell, A. W., Anyanwu, E., Kashanian, A., Bock, K., & Vojdani, E. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00180-7 · Cited by 197
“Immune abnormalities in autism include changes in the numbers and activities of macrophages, T-cells, Bcells and natural killer cells (Warren et al., 1986; 1987; Gupta et al., 1998).”
BackgroundReduced Natural Killer Cell Activity in Autism
WARREN, R. P., FOSTER, A., & MARGARETTEN, N. C. (1987) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-198705000-00008 · Cited by 190
Self-citationAutism: Review of neurochemical investigation
Cook, E. H. (1990) · Synapse · doi:10.1002/syn.890060309 · Cited by 187
“Several investigators have reported abnormal cell-mediated immunity in patients with autism (Ferrari et al., 1988; Singh et al., 1988; Stubbs et al., 1977; Warren et al., 1986,1987; Weizman et al., 1982).”
BackgroundHigh nitric oxide production in autistic disorder: a possible role for interferon-γ
Sweeten, T. L., Posey, D. J., Shankar, S., & McDougle, C. J. (2004) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.09.001 · Cited by 172
Novel treatments for autistic spectrum disorders
Levy, S. E., & Hyman, S. L. (2005) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20062 · Cited by 171
“Reported findings include decreased natural killer cell cytotoxicity [Warren et al., 1987]; alteration in CD 4:CD 8 [Warren et al., 1986; Plioplys et al., 1994]; lower levels of Th1 cells and resultant lower levels of IL2, IFNgamma, and natural killer cell activity [Gupta et al., 1998]; and…”
BackgroundImmune Dysfunction in Autism: A Pathway to Treatment
Careaga, M., Van de Water, J., & Ashwood, P. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.003 · Cited by 159
Autism: a mitochondrial disorder?
Lombard, J. (1998) · Medical Hypotheses · doi:10.1016/s0306-9877(98)90270-5 · Cited by 160
“These have included decreased number of T-lymphocytes ( 22 ), with altered ratios of helper to suppressor T-cells, and decreased natural killer cell activity (23).”
BackgroundBrain‐Specific Autoantibodies in the Plasma of Subjects with Autistic Spectrum Disorder
CABANLIT, M., WILLS, S., GOINES, P., ASHWOOD, P., & VAN DE WATER, J. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1381.010 · Cited by 157
Gupta, S., Aggarwal, S., & Heads, C. (1996) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02172828 · Cited by 156
“An increase in serum immunoglobulius observed in the present study and reported and depressed cell-mediated responses (Stubbs et al., 1977; Warren et al., 1986 ) in autism may suggest a shift in the T helper cell population from TH1 to Tn2 type (Romagnani, 1995) in a subset of patients with autism.”
BackgroundInfluentialHalsey, N. A., Hyman, S. L., & Panel, T. C. W. (2001) · Pediatrics · doi:10.1542/peds.107.5.e84 · Cited by 155
Prognosis in autism: do specialist treatments affect long-term outcome?
Howlin, P. (1997) · European Child & Adolescent Psychiatry · doi:10.1007/bf00566668 · Cited by 152
In Search of Cellular Immunophenotypes in the Blood of Children with Autism
Ashwood, P., Corbett, B. A., Kantor, A., Schulman, H., Van de Water, J., & Amaral, D. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019299 · Cited by 140
“Previous reports have demonstrated differences in lymphocyte populations in autism, including increased numbers of NK cells [14] and reduced numbers of T cells [10,19,20,46,47] or altered activation status of T cell subsets [8,21].”
BackgroundResultHigh Blood Monocyte Counts and Neopterin Levels in Children With Autistic Disorder
Sweeten, T. L., Posey, D. J., & McDougle, C. J. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.9.1691 · Cited by 151
“Although the etiology is unknown, immune system dysfunction has been hypothesized to contribute to the pathophysiology (1).”
BackgroundAdvances in understanding the pathophysiology of autism spectrum disorders
Yenkoyan, K. B., Grigoryan, A., Fereshetyan, K., & Yepremyan, D. (2017) · Behavioural Brain Research · doi:10.1016/j.bbr.2017.04.038 · Cited by 166
“One of the first valuable reports published in mid 1980s in this field was based on the study of 31 patients with ASD, which revealed several abnormalities of the immune system, including reduced responsiveness in the lymphocyte blastogenesis assay to phytohemagglutinin, concanavalin A and pokeweed mitogen [39].”
Immune Abnormalities in Autism Spectrum Disorder—Could They Hold Promise for Causative Treatment?
Gładysz, D., Krzywdzińska, A., & Hozyasz, K. K. (2018) · Molecular Neurobiology · doi:10.1007/s12035-017-0822-x · Cited by 127
“However, the majority of studies assessing B-cell number and function did not detect any abnormalities [79, 80, 85, 117].”
BackgroundStrong association of the third hypervariable region of HLA-DRβ1 with autism
Warren, R. P., Odell, J. D., Warren, W. L., Burger, R. A., Maciulis, A., Daniels, W. W., & Torres, A. R. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00052-5 · Cited by 130
“Moreover, a fairly impressive volume of evidence has accumulated suggesting that many autistic subjects have immune imbalances including numbers and functions of T cells and their subsets (Stubbs et al., 1977; Warren et al., 1986, 1990; Yonk et al., 1990;)”
BackgroundSelf-citationIncreased serum albumin, γ globulin, immunoglobulin IgG, and IgG2 and IgG4 in autism
CROONENBERGHS, J., WAUTERS, A., DEVREESE, K., VERKERK, R., SCHARPE, S., BOSMANS, E., EGYED, B., DEBOUTTE, D., & MAES, M. (2002) · Psychological Medicine · doi:10.1017/s0033291702006037 · Cited by 128
“The findings include: decreased lymphocyte transformation in response to mitogens (Stubbs & Crawford, 1997; Warren et al. 1986), decreased numbers of T-lymphocytes, a lowered CD4+}CD8+ ratio, reduced natural killer cell (NKC) cytotoxicity, a lower percentage of lymphocytes expressing the interleukin-2 receptor (IL-2R)…”
Backgroundvan Gent, T., Heijnen, C. J., & Treffers, P. D. A. (1997) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.1997.tb01518.x · Cited by 139
Genetic and Immunologic Considerations in Autism
Korvatska, E., Van de Water, J., Anders, T. F., & Gershwin, M. E. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0479 · Cited by 127
Effect of pioglitazone treatment on behavioral symptoms in autistic children.
Boris, M., Kaiser, C. C., Goldblatt, A., Elice, M. W., Edelson, S. M., Adams, J. B., & Feinstein, D. L. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-3 · Cited by 129
“These findings of abnormal T-lymphocyte function have been replicated by other investigators [9,10].”
Low natural killer cell cytotoxic activity in autism: The role of glutathione, IL-2 and IL-15
Vojdani, A., Mumper, E. A., Granpeesheh, D., Mielke, L., Traver, D., Bock, K., Hirani, K., Neubrander, J. A., Woeller, K. N., O’Hara, N., et al. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.09.005 · Cited by 133
“Immune abnormalities in autism include changes in the numbers and activities ofmacrophages, Tcells, B cells andnatural killer (NK) cell activity (Ashwood et al., 2004; Ashwood et al., 2006; Ashwood and Wakefield, 2006; Stubbs et al.,1977;Warren et al.,1986,1987).”
A Review of Autism and the Immune Response
Ashwood, P., & Van de Water, J. (2004) · Journal of Immunology Research · doi:10.1080/10446670410001722096 · Cited by 123
“mitogens (Stubbs and Crawford, 1977; Warren et al., 1986), incomplete or partial T cell activation evinced by increased numbers of DRþT cells without the expression of the IL-2 receptor (Plioplys et al.”
BackgroundJeste, D. V., Lacro, J. P., Palmer, B. W., Rockwell, E., Harris, M. J., & Caligiuri, M. P. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.309 · Cited by 127
“A previous report (3) provided data on 189 of these 307 patients.”
BackgroundMethodResultInfluentialDevelopment and Validation of the Immune Status Questionnaire (ISQ)
Versprille, L. J. F. W., van de Loo, A. J. A. E., Mackus, M., Arnoldy, L., Sulzer, T. A. L., Vermeulen, S. A., Abdulahad, S., Huls, H., Baars, T., Scholey, A. B., et al. (2019) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph16234743 · Cited by 121
“For example, altered immune functioning may have a pronounced effect on normal physiological processes but is also involved in the pathology of various chronic diseases as well as certain psychiatric disorders such as depression and autism [11,12].”
BackgroundMacrophage migration inhibitory factor and autism spectrum disorders
Grigorenko, E. L., Han, S. S., Yrigollen, C. M., Leng, L., Mizue, Y., Anderson, G. M., Mulder, E. J., de Bildt, A., Minderaa, R. B., Volkmar, F. R., et al. (2008) · PEDIATRICS · doi:10.1542/peds.2007-3604 · Cited by 118
Dietert, R. R., & Dietert, J. M. (2008) · Journal of Toxicology and Environmental Health, Part B · doi:10.1080/10937400802370923 · Cited by 113
“The immunosuppression included T-cell deficits, altered immune responses, and reduced natural killer (NK) cell activity (Stubbs & Crawford, 1977; Warren et al., 1986, 1987, 1990; Yonk et al., 1990; Ferrante et al., 2003).”
BackgroundLymphocyte Function in Autism and Rett Syndrome
Plioplys, A. V., Greaves, A., Kazemi, K., & Silverman, E. (2008) · Neuropsychobiology · doi:10.1159/000119056 · Cited by 112
Deficiency of Suppressor-Inducer (Cd4+Cd45ra+) T Cells in Autism
Warren, R. P., Yonk, L. J., Burger, R. A., Cole, P., Odell, J. D., Warren, W. L., White, E., & Singh, V. K. (1990) · Immunological Investigations · doi:10.3109/08820139009041839 · Cited by 108
Self-citationCD4+ helper T cell depression in autism
Yonk, L. J., Warren, R. P., Burger, R. A., Cole, P., Odell, J. D., Warren, W. L., White, E., & Singh, V. K. (1990) · Immunology Letters · doi:10.1016/0165-2478(90)90205-5 · Cited by 109
Self-citationIncreased frequency of the null allele at the complement C4b locus in autism
WARREN, R. P., SINGH, V. K., COLE, P., ODELL, J. D., PINGREE, C. B., WARREN, W. L., & WHITE, E. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1991.tb05657.x · Cited by 109
Self-citationLymphocyte subsets and interleukin-2 receptors in autistic children
Denney, D. R., Frei, B. W., & Gaffney, G. (1996) · Journal of Autism and Developmental Disorders · doi:10.1007/bf02276236 · Cited by 105
“by CD2 or CD3 monoclonal antibodies (Warren et al., 1990; Wright et al., 1990) or by rosetting techniques ( Warren et al., 1986 ).”
BackgroundMethodResultInfluentialSaresella, M., Marventano, I., Guerini, F. R., Mancuso, R., Ceresa, L., Zanzottera, M., Rusconi, B., Maggioni, E., Tinelli, C., & Clerici, M. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.06.020 · Cited by 109
Tsai, L. Y. (1999) · Psychosomatic Medicine · doi:10.1097/00006842-199909000-00008 · Cited by 99
Sanctuary, M. R., Kain, J. N., Angkustsiri, K., & German, J. B. (2018) · Frontiers in Nutrition · doi:10.3389/fnut.2018.00040 · Cited by 107
“Changes in numbers and activation of macrophages, T cells, B cells, and natural killer cells have all been observed in patients with ASD (29, 30).”
BackgroundIntravenous Immunoglobulin Treatment of Children With Autism
Plioplys, A. V. (1998) · Journal of Child Neurology · doi:10.1177/088307389801300207 · Cited by 93
Effectiveness of N,N-Dimethylglycine in Autism and Pervasive Developmental Disorder
Kern, J. K., Miller, V. S., Cauller, L., Kendall, R., Mehta, J., & Dodd, M. (2001) · Journal of Child Neurology · doi:10.1177/088307380101600303 · Cited by 86
Hornig, M., & Lipkin, W. I. (2001) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.1028 · Cited by 89
“…Barak et al., 1995; 1999; Ticher et al., 1996; Torrey et al., 1997; Stevens et al., 2000], and linkage to viral and/or immune factors [Chess, 1971; Warren et al., 1986; 1987; 1990; 1991; 1994; 1995; Singh et al., 1991; 1993; 1997a,b; 1998; Singh, 1996; 1997; Burger and Warren, 1998; Warren, 1998;…”
InfluentialSingh, V. K., Warren, R. P., Odell, J. D., & Cole, P. (1991) · Clinical Immunology and Immunopathology · doi:10.1016/s0090-1229(05)80015-7 · Cited by 89
Self-citationThe neuropathology of autism: where do we stand?
Schmitz, C., & Rezaie, P. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00872.x · Cited by 84
Possible association of the exetended MHC haplotype B44-SC30-DR4 with autism
Warren, R. P., Singh, V. J., Cole, P., Odell, J. D., Pingree, C., Warren, W. L., DeWitt, C., & McCullough, M. (1992) · Immunogenetics · doi:10.1007/bf00215048 · Cited by 87
Self-citationPlasma cytokine levels in children with autistic disorder and unrelated siblings
Manzardo, A. M., Henkhaus, R. S., Dhillon, S., & Butler, M. G. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2011.12.003 · Cited by 90
“This observation was replicated by Warren et al. (1986) in children with ASD and reduced number of T lymphocytes were found especially CD4+ cells required for normal immune system function and later confirmed by Denney et al. (1996).”
ResultGriffiths, K. K., & Levy, R. J. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/4314025 · Cited by 93
Immunological Aetiology of Major Psychiatric Disorders: Evidence and Therapeutic Implications
Sperner‐Unterweger, B. (2005) · Drugs · doi:10.2165/00003495-200565110-00004 · Cited by 98
Detection of Maternal Antibodies in Infantile Autism
WARREN, R. P., COLE, P., ODELL, J. D., PINGREE, C. B., WARREN, W. L., WHITE, E., YONK, J., & SINGH, V. K. (1990) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199011000-00005 · Cited by 82
Self-citationInfection in the First 2 Years of Life and Autism Spectrum Disorders
Rosen, N. J., Yoshida, C. K., & Croen, L. (2007) · PEDIATRICS · doi:10.1542/peds.2006-1788 · Cited by 86
Antibrain antibodies in infantile autism
Todd, R. D., Hickok, J. M., Anderson, G. M., & Cohen, D. J. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90012-1 · Cited by 81
The promise and the pitfalls of autism research: An introductory note for new autism researchers
Amaral, D. G. (2011) · Brain Research · doi:10.1016/j.brainres.2010.11.077 · Cited by 75
“Some of the earliest indications of an immune component to autism came from the work of the late Reed Warren and colleagues [45,46] who demonstrated a number of immunological irregularities in at least a subset of individuals with autism.”
BackgroundResultB Lymphocyte Antigen D8/17 and Repetitive Behaviors in Autism
Hollander, E., DelGiudice-Asch, G., Simon, L., Schmeidler, J., Cartwright, C., DeCaria, C. M., Kwon, J., Cunningham-Rundles, C., Chapman, F., & Zabriskie, J. B. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.2.317 · Cited by 79
Brief Report: A Pilot Open Clinical Trial of Intravenous Immunoglobulin in Childhood Autism
DelGiudice-Asch, G., Simon, L., Schmeidler, J., Cunningham‐Rundles, C., & Hollander, E. (1999) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1023096728131 · Cited by 79
“Odell, & Cole, 1991; Warren, Foster, & Margaretten, 1987; Warren, Foster, Margaretten, & Pace, 1986; Warren, Singh, et al., 1990, 1992; Warren, Yonk, et al., 1990; Yonk et al., 1990).”
Brief Report: Immune Factors in Autism: A Critical Review
Krause, I., He, X.-S., Gershwin, M. E., & Shoenfeld, Y. (2002) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1016391121003 · Cited by 80
Phenotypic expression of Autoimmune Autistic Disorder (Aad): A Major subset of Autism
Singh, V. K. (2009) · Annals of Clinical Psychiatry · doi:10.1177/104012370902100303 · Cited by 73
A novel blood-based biomarker for detection of autism spectrum disorders
Momeni, N., Bergquist, J., Brudin, L. H., Behnia, F., Sivberg, B. V., Joghataei, M. T., & Persson, B. L. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.19 · Cited by 78
Siniscalco, D., Sapone, A., Giordano, C., Cirillo, A., de Novellis, V., de Magistris, L., Rossi, F., Fasano, A., Maione, S., & Antonucci, N. (2011) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-011-1373-z · Cited by 73
Decreased cellular IL-23 but not IL-17 production in children with autism spectrum disorders
Onore, C. E., Enstrom, A. M., Krakowiak, P., Hertz‐Picciotto, I., Hansen, R., de Water, J. V., & Ashwood, P. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.09.005 · Cited by 79
“Previously, partial/incomplete or hypoactive T cell responses have been demonstrated in autism individuals following activation (Warren et al., 1986; Plioplys et al., 1994; Denney et al., 1996), Neurogenesis is influenced by the interaction between T cells and CNS-microglia cells, whereby too little or too much immune…”
Autism, an extreme challenge to integrative medicine. Part: 1: The knowledge base.
Kidd, P. M. (2002) · PubMed · Cited by 94
Autism and immune factors: A comprehensive review
Stigler, K. A., Sweeten, T. L., Posey, D. J., & McDougle, C. J. (2009) · Research in Autism · doi:10.1016/j.rasd.2009.01.007 · Cited by 70
Hyperbaric oxygen therapy might improve certain pathophysiological findings in autism
Rossignol, D. A. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.09.064 · Cited by 68
“Serum IgA fl [139] › [165] Serum IgE › [148,139] fl [164] Lymphocytic activity fl [155] › [166] T-helper cells fl [143] › [165] HBOT and immune function”
BackgroundInfluentialImmunological Treatments for Autism
Gupta, S. (2000) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1005568027292 · Cited by 78
“autism (Gupta, Aggarwal, & Heads, 1996; Menage, Thibault, Barthelemy, Lelord, & Bardos, 1992; Warren, Foster, & Margaretten, 1987; Warren, Foster, Margaretten, Pace, & Foster, 1986; Yonk et al., 1990).”
Hyperserotoninemia and Altered Immunity in Autism
Burgess, N. K., Sweeten, T. L., McMahon, W. M., & Fujinami, R. S. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0100-7 · Cited by 68
Utilization of Lymphoblastoid Cell Lines as a System for the Molecular Modeling of Autism
Baron, C. A., Liu, S. Y., Hicks, C., & Gregg, J. P. (2006) · Journal of Autism and Developmental Disorders · doi:10.1007/s10803-006-0134-x · Cited by 69
“These genes have not been previously associated with autism, but their detection in our microarray experiments may tie in with the long-standing hypothesis of suppression or dysregulation of the immune system in individuals with autism (Warren et al., 1986).”
Theoretical aspects of autism: biomarkers—a review
Ratajczak, H. V. (2011) · Journal of Immunotoxicology · doi:10.3109/1547691x.2010.538749 · Cited by 63
HLA Immune Function Genes in Autism
Torres, A., Westover, J. B., & Rosenspire, A. J. (2012) · Autism Research and Treatment · doi:10.1155/2012/959073 · Cited by 63
“It was noted that there were decreased numbers of T-lymphocytes and an altered ratio of suppressor Tlymphocytes to helper T-lymphocytes [66, 67] and altered Tlymphocytes responses in children with autism [68].”
BackgroundImmunological alterations in adult obsessive-compulsive disorder
Marazziti, D., Presta, S., Pfanner, C., Gemignani, A., Rossi, A., Sbrana, S., Rocchi, V., Ambrogi, F., & Cassano, G. B. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00371-0 · Cited by 57
Thimerosal induces TH2 responses via influencing cytokine secretion by human dendritic cells
Agrawal, A., Kaushal, P., Agrawal, S., Gollapudi, S. V. S., & Gupta, S. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.0706467 · Cited by 55
Brief Report: Immunoglobulin a Deficiency in a Subset of Autistic Subjects
Warren, R. P., Odell, J. D., Warren, W. L., Burger, R. A., Maciulis, A., Daniels, W. W., & Torres, A. R. (1997) · Journal of Autism and Developmental Disorders · doi:10.1023/a:1025895925178 · Cited by 61
Self-citationVojdani, A., Bazargan, M., Vojdani, E., Samadi, J., Nourian, A. A., Eghbalieh, N., & Cooper, E. L. (2004) · Clinical and Vaccine Immunology · doi:10.1128/cdli.11.3.515-524.2004 · Cited by 53
“Immune abnormalities in autism include changes in the numbers and activities of macrophages, T cells, B cells, and natural killer cell activity (53, 54).”
BackgroundEllul, P., Rosenzwajg, M., Peyre, H., Fourcade, G., Mariotti‐Ferrandiz, E., Trebossen, V., Klatzmann, D., & Delorme, R. (2021) · Molecular Autism · doi:10.1186/s13229-021-00472-4 · Cited by 56
The Neuroimmunological Basis of Behavior and Mental Disorders
Siegel, A., & Zalcman, S. S. (2008) · Springer eBooks · doi:10.1007/978-0-387-84851-8 · Cited by 52
“Similarly, T cell and B cell response to pokeweed mitogen can be impaired (Warren et al., 1986).”
BackgroundThe association of MHC genes with autism
Anthony, R. T. (2001) · Frontiers in bioscience · doi:10.2741/torres · Cited by 49
“It has also been shown that autistic subjects have decreased responsiveness to T-cell mitogens (7, 8), reduced numbers of helper T-cells and suppressor-inducer T-cells (9) as well as decreased natural killer cell activity (10).”
BackgroundPrenatal and postnatal neuroimmune interactions in neurodevelopmental disorders
Kim, E., Huh, J. R., & Choi, G. B. (2024) · Nature Immunology · doi:10.1038/s41590-024-01797-x · Cited by 52
“Several reports indicate that children with ASD exhibit atypical compositions of immune cell subsets compared to children with typical development 50,63 .”
Immune Therapy in Autism: Historical Experience and Future Directions with Immunomodulatory Therapy
Chez, M. G., & Guido-Estrada, N. (2010) · Neurotherapeutics · doi:10.1016/j.nurt.2010.05.008 · Cited by 53
Cook, E. H., Perry, B. D., Dawson, G., Wainwright, M. S., & LEVENTHAL, B. L. (1993) · Journal of Autism and Developmental Disorders · doi:10.1007/bf01066419 · Cited by 47
“Following this presentation of an autoimmune hypothesis of autism, other findings of abnormalities of cellmediated immunity in patients with autism have been reported (Ferrari et al., 1988; Singh, Fudenberg, Emerson, & Coleman, 1988; Stubbs, Crawford, Burger, & Vandenbark, 1977; Warren, Margaretten, & Foster, 1987; Wa…”
Animal models of autism spectrum disorders: Information for neurotoxicologists
Halladay, A. K., Amaral, D. G., Aschner, M., Bolivar, V. J., Bowman, A. B., DiCicco-Bloom, E. M., Hyman, S. L., Keller, F., Lein, P. J., Pessah, I. N., et al. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.07.002 · Cited by 47
“Evidence has been accumulating for over 20 years suggesting that immune factors may play a role in the etiology of some forms of autism (Warren et al., 1986, 1996 Institute have conducted comprehensive evaluations of children with autism and their parents to determine what, if any, perturbations of…”
Wasilewska, J., Kaczmarski, M., Stasiak-Barmuta, A., Tobolczyk, J., & Kowalewska, E. (2012) · Archives of Medical Science · doi:10.5114/aoms.2012.28561 · Cited by 45
“, only children expressing the complete syndrome of autistic disorder had significantly reduced numbers of both total T cells and CD4 cells [40].”
BackgroundAltered Sulfur Amino Acid Metabolism In Immune Cells of Children Diagnosed With Autism
Suh, J. H., Walsh, W. J., McGinnis, W. R., Lewis, A. T., & Ames, B. N. (2008) · American journal of biochemistry & biotechnology/American journal of biochemistry and biotechnology · doi:10.3844/ajbbsp.2008.105.113 · Cited by 46
“contribute to the observed imbalance between Th-1/Th2 responses reported in autism patients ([6,8,33,34]).”
BackgroundFilipek, P. A. (2005) · Handbook of Autism and Pervasive Developmental Disorders · doi:10.1002/9780470939345.ch20 · Cited by 40
Trajkovski, V., Ajdinski, L., & Spiroski, M. Z. (2004) · PubMed · doi:10.31235/osf.io/vrt3b · Cited by 48
“IgE), decreased natural killer cells and other T-cell abnormalities may reflect the “disregulation” of the immune system in persons with autism ( 12 ).”
BackgroundTianeptine: a novel strategy of psychopharmacological treatment of children with autistic disorder
Niederhofer, H., Staffen, W., & Mair, A. (2003) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.491 · Cited by 40
Bradstreet, J. J., Smith, S. A., Granpeesheh, D., El-Dahr, J. M., & Rossignol, D. A. (2006) · Medical Hypotheses · doi:10.1016/j.mehy.2006.10.015 · Cited by 40
“As mentioned previously, Scifo et al. found that the therapeutic benefit of low dose naltrexone in children with autism was associated with a reduction in cytotoxic T-cells and the normalization of the CD4/CD8 ratio.”
BackgroundInfluential
Metadata
- Authors
- Warren, R. P., Margaretten, N. C., Pace, N. C., & Foster, A.
- Affiliations
- Utah State University (US)
- Primary Children's Hospital (US)
- Venue
- Journal of Autism and Developmental Disorders
- Published
- 1986-06
- Volume
- 16
- Issue
- 2
- Pages
- 189-197
- ISSN
- 0162-3257 (ISSN-L)
- 1573-3432
- OpenAlex
- W2009755884
- Cited by
- 207
- References
- 17
- Citations by year
- 2026: 3 · 2024: 4 · 2023: 3 · 2022: 2 · 2021: 9 · 2020: 4 · 2019: 5 · 2018: 5 · 2017: 2 · 2016: 3 · 2015: 6 · 2014: 1 · 2013: 3 · 2012: 8
- FWCI
- 1.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Autism and Developmental Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
- Keywords
- autism spectrum disorder, immune abnormalities, lymphocyte proliferation, T cells, phytohemagglutinin, concanavalin A, pokeweed mitogen
- MeSH terms
- Adolescent, Adult, Anticonvulsants, Autistic Disorder, Child, Child, Preschool, Concanavalin A, Female, T-Lymphocytes, Helper-Inducer, Humans, Leukocyte Count, Lymphocytes, Male, Phytohemagglutinins, Pokeweed Mitogens, T-Lymphocytes, T-Lymphocytes, Regulatory
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.